Loading... Please wait...

Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets

Bookmark and Share
Price:
$2,500.00
Publication Date:
July 2012; Pages: 279
File Type:
Downloadable PDF


Description


Clinical Laboratory Testing Sample

Clinical laboratory in vitro diagnostic (IVD) testing for reagent and instrument sales is one of the most important sectors of medical care. By all accounts, it is a very mature, large market employing over 100,000 laboratory workers and spawning an industry for reagents and instruments comprised of thousands of companies worldwide. The term clinical laboratory testing usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations. The purpose of this TriMark Publications report is to describe the specific segments of the global clinical laboratory instrumentation and reagent market. Within this area, the report covers segments that are highly active in terms of innovation and growth. Specifically, this clinical laboratory testing report examines the markets for small lab equipment all the way up to highly-automated, large lab platforms, as well as accessory equipment such as reagents, supplies and manufacturers' original equipment manufacturer (OEM) additional equipment. The emphasis is on companies and products that are actively developing and marketing laboratory analyzer products for the clinical setting, including hospitals, independent labs, physician's offices and miscellaneous clinics. This study concentrates on the clinical laboratory instrumentation industry market segment and the companion reagents sector in the U.S. and around the world. The regional markets and their differences are examined, including in Europe, Asia (Japan, China and India) and the rest of the world (ROW).

 

TABLE OF CONTENTS

1. Overview 8
1.1 Objectives of the Report 8
1.2 Methodology 9
1.3 Scope of the Report 10
1.4 Executive Summary 11

2. IVD Industry 19
2.1 Industry Overview 19
2.2 IVD Industry Leading Players Comparison and Review 19
2.2.1 Roche Diagnostics 20
2.2.2 Abbott Laboratories 22
2.2.3 Siemens Healthcare Diagnostics 25
2.2.4 Becton, Dickinson & Co. 26
2.2.5 Beckman Coulter, Inc. 26
2.2.6 Ortho-Clinical Diagnostics 31
2.2.7 bioMérieux 32
2.2.8 Sysmex 32
2.2.9 Bio-Rad Laboratories, Inc. 32
2.2.10 ARKRAY, Inc. 33
2.2.11 Cytyc Corporation (A Hologic Company) 33
2.2.12 Gen-Probe, Inc. 33
2.3 Biotechnology Reagents and Supplies 34
2.3.1 Vendor Quality Assurance 36
2.3.2 Partnership Support 36
2.3.3 Protecting Supply of Raw Materials 37
2.3.4 Selecting a Second Source for Chemicals 38
2.3.5 Cost Analysis for Reagent Manufacture 39
2.3.6 Outsourcing Production of Reagents 39
2.4 The Fastest Growing IVD Reagent Markets 39
2.5 High Growth Applications Spur Industry Growth 40
2.6 Automated Instrument Platforms Evolution 41
2.7 Reagents and Supplies Market for Clinical Lab Instruments 41
2.8 Spending for Clinical Laboratory Testing 41
2.8.1 Reimbursement Pressure 42
2.8.2 Medicare Part B Spending Trends 43
2.8.3 Strategies for Revenue Growth 45
2.8.4 Electronic Health Records 45

3. IVD Clinical Laboratory Instrument and Reagent Market 46
3.1 Markets 46
3.1.1 Global Markets 46
3.1.2 Global Drivers of Clinical Laboratory Testing 48
3.1.3 Global Outlook 49
3.1.4 U.S. Market 50
3.1.5 European IVD Instruments and Reagents Market 54
3.1.5.1 German Clinical Laboratory Diagnostic Markets 63
3.1.5.2 U.K. Clinical Laboratory Testing Diagnostic Product Market 65
3.1.5.2.1 U.K. Competitive Analysis 65
3.1.5.2.2 U.K. Market Access 67
3.1.5.3 French Clinical Laboratory Diagnostic Testing Products Market 67
3.1.5.4 Italian Clinical Laboratory Diagnostic Products Market 68
3.1.5.5 Spanish Clinical Laboratory Diagnostic Market 69
3.1.5.6 Finnish Clinical Laboratory Products Market 70
3.1.5.7 Turkish Clinical Laboratory Products Market 71
3.1.5.8 Belgium Clinical Laboratory Diagnostic Products Market 72
3.1.5.9 Swiss Clinical Laboratory Diagnostic Products Market 72
3.1.5.10 Dutch Clinical Laboratory Diagnostic Products Market 73
3.1.5.11 Portuguese Clinical Laboratory Diagnostic Products Market 73
3.1.5.12 Austrian Clinical Laboratory Diagnostic Products Market 74
3.1.5.13 Greek Clinical Laboratory Diagnostic Products Market 75
3.1.5.14 Polish Clinical Laboratory Diagnostic Products Market 75
3.1.5.15 Romanian Clinical Laboratory Diagnostic Products Market 76
3.1.5.16 Czech Republic Clinical Laboratory Diagnostic Products Market 77
3.1.5.17 Swedish Clinical Laboratory Diagnostic Products Market 77
3.1.5.18 Norwegian Clinical Laboratory Diagnostic Products Market 78
3.1.5.19 Irish Clinical Laboratory Diagnostic Products Market 78
3.1.5.20 Hungarian Clinical Laboratory Diagnostic Products Market 79
3.1.5.21 Bulgarian Clinical Laboratory Diagnostic Products Market 79
3.1.5.22 Slovakian Clinical Laboratory Diagnostic Products Market 80
3.1.5.23 Lithuanian Clinical Laboratory Diagnostic Products Market 81
3.1.5.24 Latvian Clinical Laboratory Diagnostic Products Market 81
3.1.5.25 Estonian Clinical Laboratory Diagnostic Products Market 82
3.1.5.26 Slovenian Clinical Laboratory Products Diagnostic Market 82
3.1.5.27 Russian Clinical Laboratory Diagnostic Products Market 83
3.1.6 Asian Markets 83
3.1.6.1 Indian Clinical Laboratory Diagnostic Products Market 85
3.1.6.1.1 Indian IVD Testing Instrument and Reagents Industry 85
3.1.6.2 Japanese Clinical Laboratory Testing Products Market 91
3.1.6.3 Chinese Clinical Laboratory Instrument and Reagent Market 92
3.1.7 Clinical Laboratory Smaller Country Markets 103
3.1.7.1 Canadian Clinical Laboratory Market 103
3.1.7.2 Brazilian Clinical Laboratory Instrument and Reagent Market 103
3.1.7.3 Australian Clinical Laboratory Instrument and Reagent Market 105
3.1.8 ROW Clinical Laboratory Testing Instrument and Reagent Market 105
3.1.9 Overview of Asian Clinical Laboratory Instrument and Reagent Market 106
3.1.9.1 Singapore 107
3.1.9.2 Malaysia 109
3.1.9.3 Thailand 109
3.1.9.4 Indonesia 110
3.1.9.5 Philippines 110
3.1.9.6 South Korea 110
3.1.9.7 India 111
3.1.9.8 Hong Kong 111
3.1.9.9 Taiwan 111
3.1.10 Overview of the Latin American Diagnostics Market 112
3.2 Clinical Laboratory Sector 113
3.2.1 Key Industry Players 113
3.2.2 Market Specialization 116
3.2.3 Revenue and Reimbursement 118
3.2.4 Companies 119
3.3 Outlook for Clinical Laboratory Testing 120
3.3.1 Long-term Changes 120
3.3.2 Market Drivers 121
3.3.3 The Limits to Growth 123
3.3.4 Hot Sectors in the IVD Market 123
3.3.5 Key Technologies 125
3.3.6 Conclusion 125

4. Clinical Laboratory Instrument Market by Sector 127
4.1 Chemistry Analyzers 127
4.1.1 Ultra-Large Throughput Laboratory Analyzers 127
4.1.2 Large-Throughput Analyzers 134
4.1.3 Mid-size Clinical Laboratory Analyzers 145
4.1.4 Laboratory Analyzers for the Small Volume Market 148
4.2 Immunochemistry Analyzers 155
4.2.1 Large Immunochemistry Analyzers 155
4.2.2 Small Immunoassay Analyzers 163
4.3 Hematology Analyzers 166
4.4 Point of Care Testing 181
4.5 Microbiology Testing 186
4.6 Serology Testing 186
4.7 Esoteric Testing 186
4.8 Anatomic Pathology 187
4.8.1 Histology 188
4.8.2 IHC Staining 189
4.8.3 ISH Staining 189
4.8.4 Special Stains Staining 189
4.8.5 Tissue Staining Market 189
4.8.6 Cancer Diagnostics; Anatomic Pathology 190
4.9 Drug Testing 190

5. Important Technology Trends in IVD Instrumentation and Reagents 196
5.1 Technology Innovations in Instrument and Reagent Development 196
5.2 Sensor Systems for Diagnostic Applications 196
5.3 Glucose Measurements 201
5.4 Glucose Test Methods 204
5.5 Cholesterol Measurements 205
5.6 The New Paradigm 205
5.7 Consolidated Workstations 205
5.8 Automation in the Laboratory 207
5.9 Laboratory Information Systems 208
5.10 New User-friendly Interfaces 209
5.11 Biosensor Technology 210
5.12 Data-Management Issues 212
5.12.1 Wireless LANs 212
5.12.2 Cepheid’s POC GBS and BCR/ABL Tests 212
5.12.3 Data and Workflow Management Systems 213
5.12.4 Beckman Central Command 213

6. Business Trends in the Clinical Laboratory Analyzer and Reagents Market 215
6.1 Key Market Developments 215
6.1.1 Decreasing Revenue from Traditional IVD Markets 215
6.1.2 High Growth in POCT and Molecular Diagnostics Arena 215
6.1.3 Move Away from Traditional Kit Testing Methods 216
6.1.4 Integrated Analytical Systems 217
6.1.5 Regulatory Changes 217
6.1.6 Development of a Two-Tier Industry Structure 217
6.1.7 Labor Costs 218
6.1.8 Increasing Value of Companies with High-Margin Technology Platforms 218
6.1.9 The Joining of IVD Testing and Computer Technology 218
6.1.10 User-friendly User Interfaces 219
6.2 Sector Consolidation 220
6.2.1 IVD Company Consolidation 220
6.2.2 Lab Company Consolidation 225
6.2.2.1 Acquisition Pricing 226
6.3 Diagnostic Testing Growth Trends 226
6.4 Reagent and Hardware Business in Japan 226
6.5 New Products 227
6.6 Acquisition, License Agreements, Internal Development and Partnerships 228
6.7 Product Testing Depth in Clinical Laboratory Testing 230
6.8 Government Regulation of IVD Devices 230
6.8.1 U.S. Regulation 230
6.8.1.1 Importing Medical Devices into the U.S. 232
6.8.1.2 Exporting Medical Devices from the U.S. 232
6.8.2 E.U. Regulation 233
6.8.3 Japanese Regulation 236
6.8.4 Korean Regulation 237
6.8.5 Chinese Regulation 237
6.8.6 Post Filing Regulations for Medical Devices 238
6.8.7 Exporting Unapproved POCTs 239
6.8.8 Analyte Specific Reagents (Home Brew Tests) 239
6.8.9 Medical Device Registration 240
6.8.10 Product Labeling 240
6.8.11 Punitive FDA Actions 240
6.8.12 Clinical Laboratory Improvement Act of 1988 and State Laboratory Laws 241
6.8.13 Impact of Regulations on the Industry 241
6.8.14 Minimizing Regulatory Barriers 243
6.9 Increased Market Penetration 244
6.10 Costs of Doing Business in Europe 245
6.11 Drivers of European Diagnostics Testing 245
6.12 European Reimbursement Practices 245
6.13 Cost Containment in Europe 245
6.14 Hospital Outreach Programs 247
6.15 Electronic Procurement: New Challenges 248
6.16 Competition for Supply Chain Management Solutions 250
6.17 E-Commerce in the Hospital Supply Chain 251
6.17.1 Drivers of E-Commerce Solutions 252
6.17.2 Barriers to E-Commerce Solutions 252
6.18 Top Trends in IVD Instrument and Reagent Business Practices 255
6.19 The Value of the New Diagnostics 256
6.20 Converging Technologies—Drugs and Diagnostic Tests Combine for Improved Healthcare 257
6.21 Emerging Technologies in the Downstream Manufacture of Bio-Materials 257
6.22 GMP Readiness 257
6.23 Harnessing Human Resource Capabilities and IT Prowess: Biotechnology in the Future 258
6.24 Partnering with Patient-based Organizations to Achieve Patient Health Goals 258
6.25 Rumors of the Platform Company’s Demise are Greatly Exaggerated 258
6.26 Who’s Going to Pay for It? 259
6.27 Clinical Trials Testing. 260
6.28 Life Insurer Services. 260
6.29 Employer Services 261
6.30 Waived Testing 261

7. Company Profiles 262
7.1 Abaxis 262
7.2 Abbott 265
7.3 Adaltis, Inc. 267
7.4 Alfa Wasserman, Inc. (Formerly Electro-Nucleonics, Inc. and Schiapparelli Biosystems, Inc.) 268
7.5 Becton, Dickinson & Co. 268
7.6 Beckman Coulter, Inc. 268
7.7 bioMérieux 269
7.8 Hitachi 269
7.9 Horiba Ltd. 270
7.10 JEOL Ltd. 270
7.11 MEDTOX Scientific, Inc. 271
7.12 Myriad Genetics, Inc. 271
7.13 Nova Biomedical 272
7.14 Hologic, Inc. 272
7.15 Ortho-Clinical Diagnostics, a J&J Company 273
7.16 Roche Diagnostics Corp. 275
7.17 Shimadzu 276
7.18 Sysmex Corporation 277
7.19 Thermo Fisher Scientific, Inc. 277
7.20 Vital Scientific, NV 279
7.21 Tosoh Corporation 279


INDEX OF FIGURES

Figure 1.1: Worldwide Market Share Distribution of IVD Reagent and Instrument Testing 12
Figure 1.2: Top 13 Country Market Share Distribution of IVD Reagent and Instrument Testing 13
Figure 2.1: Market Share of Top Twelve Largest Diagnostic Companies Worldwide 20
Figure 2.2: Part B Spending on Clinical Laboratory Services, 1991-2005 44
Figure 3.1: IVD Product Demand 50
Figure 3.2: Global Market for Molecular Diagnostics, 2002-2016 53
Figure 3.3: European IVD Market by Clinical Specialty 56
Figure 3.4: Chinese IVD Market, 2006-2016 96
Figure 3.5: Principal Marketers in the IVD Industry 116
Figure 4.1: Global Revenue of Drugs of Abuse Testing Market Forecast, 2007-2015 191
Figure 4.2: U.S. Revenue of Drugs of Abuse Testing Market Forecast, 2007-2015 192
Figure 4.3: E.U. Revenue of Drugs of Abuse Testing Market Forecast, 2007-2015 193
Figure 6.1: Conformity Assessment Route, Annexes and Quality System Standards by IVD
Device Category 234
Figure 6.2: Hospital Market Share for Outreach Programs 248


INDEX OF TABLES

Table 1.1: Worldwide Distribution of IVD Reagent and Instrument Testing Revenue, 2011 12
Table 1.2: Top 13 Country IVD Reagent and Instrument Testing Markets Revenues, 2011 13
Table 2.1: Top Twelve Largest Diagnostic Companies Worldwide 19
Table 2.2: Products Marketed by Abbott in the Diagnostic Market 24
Table 2.3: Beckman Coulter Market Share in Major Diagnostic Sectors 31
Table 2.4: Prodesse’s ASRs 36
Table 2.5: CMS Reimbursement for Top 25 Clinical Laboratory Procedures 44
Table 3.1: Worldwide IVD Testing Instrument and Reagent Market, 2011 46
Table 3.2: Worldwide Geographic Distribution of IVD Instrument and Reagent Markets, 2011 46
Table 3.3: Global Clinical Laboratory Instrument and Reagent Testing Market Sales, 1998-2016 47
Table 3.4: U.S. Clinical Laboratory Instrument and Reagent Testing Market, 2003-2016 51
Table 3.5: U.S. Clinical Laboratory Diagnostic Instrument and Reagent Test Market Segments, 2011 51
Table 3.6: U.S. Individual Clinical Chemistry Laboratory Diagnostic Test Markets, 2011 52
Table 3.7: U.S. Market for Molecular Diagnostics Testing, 2000-2016 53
Table 3.8: U.S. Market for Molecular Diagnostics Testing Instruments and Reagents, 2004-2016 54
Table 3.9: European Clinical Laboratory Testing IVD Reagents and Instruments Market, 2000-2016 54
Table 3.10: European Clinical Laboratory Diagnostic Testing Reagents and Instruments Market by
Analyte, 2011 55
Table 3.11: European Clinical Chemistry Testing IVD Reagents and Instruments Market, 2000-2016 55
Table 3.12: European Clinical Laboratory Testing Diagnostics by Country Market, 2011 56
Table 3.13: German Clinical Laboratory Testing Diagnostics Products Market Sales, 2003-2016 63
Table 3.14: U.K. Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 65
Table 3.15: Major U.K. IVD Manufacturers 66
Table 3.16: U.S. IVD Manufacturers Doing Business in the U.K. 66
Table 3.17: Other European Companies that Manufacture IVD Products in the U.K. 66
Table 3.18: French Clinical IVD Testing Diagnostics Products Market Sales, 2003-2016 67
Table 3.19: Italian Laboratory Diagnostics Products Market Sales, 2003-2016 69
Table 3.20: Spanish Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 70
Table 3.21: Finnish Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 71
Table 3.22: Turkish Clinical Laboratory Testing Market, 2000-2016 71
Table 3.23: Belgium Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 72
Table 3.24: Swiss Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 72
Table 3.25: Dutch Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 73
Table 3.26: Portuguese Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 74
Table 3.27: Austrian Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 74
Table 3.28: Greek Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 75
Table 3.29: Polish Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 76
Table 3.30: Romanian Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 76
Table 3.31: Czech Republic Clinical Laboratory Diagnostics Products Market Sales, 2004-2016 77
Table 3.32: Swedish Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 78
Table 3.33: Norwegian Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 78
Table 3.34: Irish Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 79
Table 3.35: Hungarian Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 79
Table 3.36: Bulgarian Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 80
Table 3.37: Slovakian Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 80
Table 3.38: Lithuanian Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 81
Table 3.39: Latvian Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 81
Table 3.40: Estonian Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 82
Table 3.41: Slovenian Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 83
Table 3.42: Russian Clinical Laboratory Diagnostics Products Market Sales, 2007-2016 83
Table 3.43: Asian Geographic Distribution of IVD Testing, 2011 84
Table 3.44: Summary of Key Business Points of the Asian Healthcare Market 84
Table 3.45: Outlook for the Asian Healthcare Market, 2010-2012 84
Table 3.46: Asian IVD Market Drivers 85
Table 3.47: Asian IVD Market Restraints 85
Table 3.48: Top Asian IVD Growth Opportunities 85
Table 3.49: Indian IVD Market for Instruments and Reagents, 2004-2016 86
Table 3.50: Number of Automated Clinical Labs in India, 2004-2016 86
Table 3.51: Indian IVD Market, 2011 87
Table 3.52: Japanese Clinical Laboratory Testing Instrument and Reagents Market, 2003-2016 91
Table 3.53: Drivers of the Japanese IVD Market 91
Table 3.54: Barriers to the Japanese IVD Market 91
Table 3.55: Japanese Population and Aging Demographics Forecast, 2000-2050 92
Table 3.56: Drivers of Growth in the Chinese Clinical Laboratory Market 93
Table 3.57: Number of Chinese Medical Institutions 94
Table 3.58: Chinese Clinical Laboratory Diagnostics Products Market Sales, 2003-2016 95
Table 3.59: Chinese IVD Instrument and Reagent Market, 2011 95
Table 3.60: Proportion of Medical Expenses Paid Privately 97
Table 3.61: Market Share of Reagent Imports into the Chinese Clinical Lab Market by Country of Origin 98
Table 3.62: Analytical Instrument Imports into the Chinese Clinical Lab Market by Country of Origin 98
Table 3.63: Chinese International IVD Manufacturers 99
Table 3.64: Chinese Domestic IVD Manufacturers 99
Table 3.65: Chinese IVD Distributors 101
Table 3.66: Canadian Clinical Laboratory Testing Instrument and Reagent Market, 2000-2011 103
Table 3.67: Brazilian Clinical Laboratory Instrument and Reagent Testing Market, 2000-2011 104
Table 3.68: Australian Clinical Laboratory Testing Instrument and Reagent Market, 2000-2011 105
Table 3.69: ROW Clinical Laboratory Testing Instrument and Reagent Market, 2000-2011 105
Table 3.70: Latin American Geographic Distribution of IVD Testing Reagents and Instruments
Markets, 2011 112
Table 3.71: Number of Clinical Laboratories in Latin America 112
Table 3.72: Key Market Drivers of Automated Clinical Laboratory Instruments 121
Table 3.73: Key Market Limits of Automated Clinical Laboratory Instruments 123
Table 4.1: Ultra-Large Clinical Laboratory Analyzers 134
Table 4.2: JEOL Analyzer Comparison 141
Table 4.3: Large Clinical Laboratory Analyzers 144
Table 4.4: Mid-size Clinical Laboratory Analyzers 148
Table 4.5: Small Clinical Laboratory Analyzers 154
Table 4.6: Large Immunochemistry Analyzers 162
Table 4.7: Small Immunoassay Analyzers 166
Table 4.8: Linearity and Precision of Abbott CELL-DYN Hematology Analyzers 169
Table 4.9: Accuracy of the Automated Differential of Abbott CELL-DYN Analyzers 169
Table 4.10: Linearity and Precision of Siemens Hematology Analyzers 170
Table 4.11: Accuracy of the Automated Differential of Siemens Hematology Analyzers 171
Table 4.12: Linearity and Precision of Beckman Coulter Hematology Instruments 173
Table 4.13: Accuracy of the Automated Differential of Beckman Coulter Hematology Analyzers 173
Table 4.14: Linearity and Precision of Horiba ABX Hematology Analyzers 175
Table 4.15: Accuracy of the Horiba ABX Hematology Analyzers 175
Table 4.16: Linearity and Precision of Sysmex Hematology Analyzers 178
Table 4.17: Accuracy of the Sysmex Hematology Analyzers 179
Table 4.18: Comparison of Linearity and Precision of Top-of-the-Line Hematology Analyzers 179
Table 4.19: Comparison of Accuracy of the Top-of-the-Line Hematology Analyzers 180
Table 4.20: Hematology Analyzers with a Five-Part WBC Differential 180
Table 4.21: Hematology Analyzers with a Three-Part WBC Differential 181
Table 4.22: Point of Care Testing 183
Table 4.23: Number of ER Visits in U.S. Hospitals, 2000-2011 185
Table 4.24: Global Revenue from Drugs of Abuse Testing, 2007-2015 191
Table 4.25: U.S. Revenue from Drugs of Abuse Testing, 2007-2015 192
Table 4.26: E.U. Revenue from Drugs of Abuse Testing, 2007-2015 193
Table 4.27: Worldwide Distribution of Drug Abuse Testing, 2011 193
Table 5.1: Normal Glucose Values—Fasting State 203
Table 5.2: Applications for Wireless LAN Technology 212
Table 6:1: Products Marketed by Abbott in the Diagnostics Market 223
Table 7.1: Abaxis Blood Analysis Diagnostic Tests 263
Table 7.2: Reagent Discs Offered with the Piccolo Chemistry Analyzers 264
Table 7.3: The VITROS ECiQ Immunodiagnostic System 27

Find Similar Products by Category